Biltmore Family Office’s Zimmer Biomet ZBH Stock Holding History

Biltmore Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,893	Closed	-$3.77M	–	225
2019 Q4	$3.77M	Hold	25,893	–	–	1.52%	17
2019 Q3	$3.45M	Buy	25,893 +12,702	+96%	+$1.64M	1.49%	17
2019 Q2	$1.51M	Hold	13,191	–	–	0.82%	37
2019 Q1	$1.64M	Hold	13,191	–	–	0.83%	40
2018 Q4	$1.33M	Hold	13,191	–	–	0.75%	44
2018 Q3	$1.69M	Hold	13,191	–	–	0.8%	38
2018 Q2	$1.43M	Hold	13,191	–	–	0.71%	44
2018 Q1	$1.4M	Sell	13,191 -270	-2%	-$31.4K	0.62%	51
2017 Q4	$1.58M	Buy	+13,461	New	+$1.52M	0.71%	46

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Biltmore Family Office's ZBH Position: Q1 2020 in Review

Biltmore Family Office sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 25,893 shares — an estimated $3.77M sold.

Biltmore Family Office first reported a position in ZBH in Q4 2017 and held it in 9 quarters. The position peaked at $3.77M in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Biltmore Family Office reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Biltmore Family Office sold 25,893 Zimmer Biomet shares in Q1 2020, an estimated $3.77M.
Biltmore Family Office first reported a position in Zimmer Biomet in Q4 2017 and held it in 9 quarters.
Biltmore Family Office's Zimmer Biomet position peaked at $3.77M in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Biltmore Family Office's 13F filing for Q1 2020, filed 8 May 2020.